ADNI data is made available to researchers around the world. As such, there are many active research projects accessing and applying the shared ADNI data. To further encourage Alzheimer’s disease research collaboration, and to help prevent duplicate efforts, the list below shows the specific research focus of the active ADNI investigations. This information is requested annually as a requirement for data access.
| Principal Investigator | |
| Principal Investigator's Name: | Haining Sun |
| Institution: | Janssen Pharmaceutical Companies of Johnson & Johnson |
| Department: | CLINICAL PROGRAMMING |
| Country: | |
| Proposed Analysis: | To gain more understanding on the process of disease progression at different stage of the AD, and to evaluate the potential relationship between multiple biomarker and clinical endpoints during the progression. |
| Additional Investigators |